Related Experiment Video
Updated: Feb 3, 2026

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
In Vitro Assays for Screening Small Molecules
Ashley A Adile1,2, David Bakhshinyan1,2, Chitra Venugopal3,4
1McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, Canada.
Abstract:
Traditionally anti-cancer therapeutics have been designed to target rapidly proliferating cells causing DNA damage and inducing apoptosis. However, with the development of the cancer stem cell (CSC) hypothesis, it has been postulated that a rare, slow dividing tumor cell population is able to escape therapy and contribute to tumor relapse and metastasis. The advances in characterization of CSCs across multiple cancer subtypes have allowed for development of targeted therapies using small molecule inhibitors. In this chapter, we describe two in vitro assays measuring proliferation and secondary sphere formation, which have become gold-standard assays to evaluate the effects of targeted therapies against CSCs. Together these assays constitute a rapid, inexpensive, and highly reproducible pipeline for testing small molecule inhibitors prior to more resource demanding in vivo studies.
Insights
Cancer stem cells (CSCs) evade traditional therapies, driving relapse. New assays rapidly evaluate targeted therapies against CSC proliferation and sphere formation, aiding drug development before in vivo studies.
Area of Science:
- Oncology
- Cancer Biology
- Drug Discovery
Background:
- Traditional anti-cancer therapies target rapidly proliferating cells, often sparing slow-dividing cancer stem cells (CSCs).
- The cancer stem cell hypothesis suggests these rare cells drive tumor relapse and metastasis.
- Targeted therapies using small molecule inhibitors are being developed to address CSCs.
Purpose of the Study:
- To describe two validated in vitro assays for evaluating targeted therapies against cancer stem cells (CSCs).
- To establish a rapid, cost-effective, and reproducible pipeline for pre-clinical drug screening.
Main Methods:
- Assay 1: Measurement of cancer stem cell (CSC) proliferation.
- Assay 2: Assessment of secondary sphere formation capacity in CSCs.
- Both assays are designed for in vitro evaluation of small molecule inhibitors.
Main Results:
- The described assays serve as gold-standard methods for evaluating targeted therapies against CSCs.
- These assays provide a robust platform for assessing the efficacy of small molecule inhibitors in targeting CSCs.
- The pipeline enables efficient screening of potential anti-cancer drugs.
Conclusions:
- The developed in vitro assays are crucial for evaluating targeted therapies against cancer stem cells (CSCs).
- This assay pipeline offers a rapid, inexpensive, and reproducible method for pre-clinical drug testing.
- These methods facilitate the advancement of novel CSC-targeted therapies towards in vivo studies.
Related Concept Videos
Molecules and Compounds
Types of Signaling Molecules
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Positive Regulator Molecules
Positive Regulator Molecules

